Prevention and Management of Delirium in Older General Medical Patients
- Conditions
- DeliriumNeurological - Other neurological disorders
- Registration Number
- ACTRN12608000204347
- Lead Sponsor
- Dr Catherine Maussen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 406
Patients are eligible for study if admitted to participating medical units; aged 65 years or greater; and at intermediate-high risk of delirium following application of screening tool.
Palliative patients; combative/dangerous behaviour; hyperactive delirium requiring AIN special >4 hours daily; non invasive ventilation/tracheostomy; post ICU; severe psychiatric disorder preventing participation in interventions; severe dementia; discharge anticipated within 72 hours admission; aphasia; any condition not listed above that prevents participation in intervention ward programme
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall incidence delirium will be measured by applying the Confusion Assessment Method (CAM)[At 48 hours, prior to discharge]
- Secondary Outcome Measures
Name Time Method Time to resolution of delirium will be measured by applying the Confusion Assessment Method (CAM) at intervals and documenting days to resolution of delirium[Day 4,7; weekly until patient discharge];Length of stay[Discharge];Documented falls[Discharge];Cognitive decline will be measured by applying either Abbreviated Mental Test (AMT) or Mini-Mental State Examination (MMSE) and functional decline through application of a modified Katz Activities of Daily Living (ADL) assessment[Admission, discharge]
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.